DRUG maker Zydus Cadila today said it will form a 50:50 joint venture with Germany's Bayer Healthcare to sell pharmaceuticals in India.The joint venture-Bayer Zydus Pharma"will operate in key segments, including women's healthcare, metabolic disorders, diagnostic imaging, cardiovascular disease, anti-diabetic treatments and oncology, the Ahmedabad-based company said.
展开▼